JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 45(2011) N 2 p. 241-250;
Zhang Zheng, Yao Ke*, Ma Jin, Tang Xiajing

Anti-inflammatory effect of the alpha-melanocyte hormone in animal eyes undergoing extracapsular lens extraction

Eye Center of Affiliated Second Hospital, School of Medicine, Zhejiang University, Hangzhou, China

*yaokezju@yahoo.cn
Received - 2010-03-09; Accepted - 2010-03-26

In this study anti-inflammatory effects of the alpha-melanocyte stimulating hormone (α-MSH) on ocular inflammation caused by extracapsular lens extraction (ECLE) have been investigated and the potential mechanism of an anti-inflammatory effect is discussed. Pigmented rabbit eyes after ECLE were treated locally with α-MSH, dexamethasone, diclofenac, or saline 4 times a day (q.i.d.) for 4 weeks. The inhibitory effect of α-MSH on infiltrating cells in the aqueous humor (AqH) was almost twice as good as that of dexamethasone or diclofenac for 3 days, 1 week, and 2 weeks after the operation. The eyes of Sprague-Dawley rats were treated with an intravenous injection of α-MSH or saline immediately after ECLE. Six hours postoperatively, the iris/ciliary body exhibited increased expression of TNF-α and IL-6 mRNAs, which were significantly decreased after α-MSH treatment. The number of activated NF-kappa B (NFκB)-positive cells in the iris/ciliary body was also significantly reduced by the α-MSH treatment. These results suggested that α-MSH could effectively reduce ocular inflammation after ECLE, and the potential mechanism for this is by down-regulating the expression of proinflammatory cytokines and inhibiting the NFκB-dependent signaling pathway.

alpha-melanocyte stimulating hormone, NF-kappa B, inflammation, tumor necrosis factor-alpha, interleukin-6



JMB-FOOTER RAS-JOURNALS